MedKoo Cat#: 584824 | Name: NLA 1

Description:

WARNING: This product is for research use only, not for human or veterinary use.

NLA 1 is a bioreductive compound.

Chemical Structure

NLA 1
CAS#140448-36-8

Theoretical Analysis

MedKoo Cat#: 584824

Name: NLA 1

CAS#: 140448-36-8

Chemical Formula: C19H18ClN5O2

Exact Mass: 383.1149

Molecular Weight: 383.84

Elemental Analysis: C, 59.45; H, 4.73; Cl, 9.24; N, 18.25; O, 8.34

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
NLA 1; NLA1; NLA-1
IUPAC/Chemical Name
9-Acridinamine, N-(3-(2-nitro-1H-imidazol-1-yl)propyl)-, monohydrochloride
InChi Key
BYQPDMUOXXCZOV-UHFFFAOYSA-N
InChi Code
InChI=1S/C19H17N5O2.ClH/c25-24(26)19-21-11-13-23(19)12-5-10-20-18-14-6-1-3-8-16(14)22-17-9-4-2-7-15(17)18;/h1-4,6-9,11,13H,5,10,12H2,(H,20,22);1H
SMILES Code
O=[N+](C1=NC=CN1CCCNC2=C(C=CC=C3)C3=NC4=CC=CC=C42)[O-].[H]Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 383.84 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Papadopoulou MV, Rosenzweig HS, Doddi M, Bloomer WD. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-1,2,3,4-tetrahydroacridine hydrochloride. A novel DNA-affinic hypoxic cell cytotoxin and radiosensitizer. Comparison with NLA-1. Oncol Res. 1994;6(9):439-48. PubMed PMID: 7703530. 2: Papadopoulou MV, Epperly MW, Shields DS, Bloomer WD. Radiosensitization and hypoxic cell toxicity of NLA-1 and NLA-2, two new bioreductive compounds. Jpn J Cancer Res. 1992 Apr;83(4):410-4. PubMed PMID: 1506276; PubMed Central PMCID: PMC5918828. 3: Denny WA, Roberts PB, Anderson RF, Brown JM, Phil D, Wilson WR. NLA-1: a 2-nitroimidazole radiosensitizer targeted to DNA by intercalation. Int J Radiat Oncol Biol Phys. 1992;22(3):553-6. PubMed PMID: 1735695. 4: Papadopoulou MV, Mainwaring A, Bloomer WD. Potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea's toxicity in vitro by two new bioreductive agents. Jpn J Cancer Res. 1992 Aug;83(8):907-13. PubMed PMID: 1399828; PubMed Central PMCID: PMC5918954.